{"entity":{"type":"insider","cik":"0001615258","url":"/insider/0001615258","json_url":"/insider/0001615258.json","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":4,"first":"2018-12-06","last":"2025-06-27","span_basis":"filed_date"},"name_variants":[{"name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","source":"filing","n_filings":4,"first_seen":"2018-12-06","last_seen":"2025-06-27"}],"transactions":[{"id":4269978,"accession":"0001140361-25-023976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-023976","line_url":"/filing/0001140361-25-023976#line-1","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":null,"owner_name":"Fosun Pharma USA Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Fosun Pharma USA Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2854607.0,"shares_display":"2,854,607","price_per_share":11.46,"price_display":"11.46","price_state":"stated","total_value":32713796.22,"total_display":"32,713,796.22","total_whole":"32,713,796","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-06-27","scope":"insider"},{"id":2686128,"accession":"0001104659-24-109317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-109317","line_url":"/filing/0001104659-24-109317#line-1","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":13.02,"price_display":"13.02","price_state":"stated","total_value":29946.0,"total_display":"29,946.00","total_whole":"29,946","shares_owned_after":64167.0,"shares_owned_after_display":"64,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":2206723,"accession":"0001104659-24-108390","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-7","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":13.12,"price_display":"13.12","price_state":"stated","total_value":17056.0,"total_display":"17,056.00","total_whole":"17,056","shares_owned_after":66467.0,"shares_owned_after_display":"66,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-14","filed_date":"2024-10-15","scope":"insider"},{"id":2206720,"accession":"0001104659-24-108390","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-6","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1580.0,"shares_display":"1,580","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":21124.6,"total_display":"21,124.60","total_whole":"21,125","shares_owned_after":67767.0,"shares_owned_after_display":"67,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2206717,"accession":"0001104659-24-108390","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-5","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":13.39,"price_display":"13.39","price_state":"stated","total_value":40170.0,"total_display":"40,170.00","total_whole":"40,170","shares_owned_after":69347.0,"shares_owned_after_display":"69,347","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-10","filed_date":"2024-10-15","scope":"insider"},{"id":2206714,"accession":"0001104659-24-108390","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-4","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1816.0,"shares_display":"1,816","price_per_share":13.36,"price_display":"13.36","price_state":"stated","total_value":24261.76,"total_display":"24,261.76","total_whole":"24,262","shares_owned_after":72347.0,"shares_owned_after_display":"72,347","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-15","scope":"insider"},{"id":2206711,"accession":"0001104659-24-108390","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-3","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":13.13,"price_display":"13.13","price_state":"stated","total_value":23634.0,"total_display":"23,634.00","total_whole":"23,634","shares_owned_after":74163.0,"shares_owned_after_display":"74,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-15","scope":"insider"},{"id":2206709,"accession":"0001104659-24-108390","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-108390","line_url":"/filing/0001104659-24-108390#line-2","is_derivative":false,"issuer_cik":"0000275053","issuer_name":"NATURES SUNSHINE PRODUCTS INC","issuer_ticker":"NATR","issuer_name_source":null,"issuer_url":"/issuer/0000275053","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1399.0,"shares_display":"1,399","price_per_share":13.54,"price_display":"13.54","price_state":"stated","total_value":18942.46,"total_display":"18,942.46","total_whole":"18,942","shares_owned_after":75963.0,"shares_owned_after_display":"75,963","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-15","scope":"insider"},{"id":6813457,"accession":"0001144204-18-063392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-063392","line_url":"/filing/0001144204-18-063392#line-1","is_derivative":false,"issuer_cik":"0001478069","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001478069","owner_cik":"0001615258","owner_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_display_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","owner_url":"/insider/0001615258","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":1224000.0,"total_display":"1,224,000.00","total_whole":"1,224,000","shares_owned_after":7900000.0,"shares_owned_after_display":"7,900,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000275053","name":"NATURES SUNSHINE PRODUCTS INC","url":"/issuer/0000275053","role":"Ten percent owner","n_filings":3,"first_seen":"2024-10-15","last_seen":"2025-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001478069","name":"CONTRAFECT Corp","url":"/issuer/0001478069","role":"Ten percent owner","n_filings":1,"first_seen":"2018-12-06","last_seen":"2018-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001615258","retrieved_at":"2026-08-22T20:32:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}